Related Experiment Videos
A symposium: from hypertension to heart failure: endothelial dysfunction and structural changes in cardiovascular
1Department of Medicine, University of Minnesota Medical School, Minneapolis 55455, USA.
The American Journal of Cardiology
|November 24, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Rationale for angiotensin II receptor blocker therapy in chronic heart failure.
Journal of the renin-angiotensin-aldosterone system : JRAAS·2007
Relationship between C-reactive protein and arterial stiffness in an asymptomatic population.
Journal of human hypertension·2005
Small and large artery elasticity indices in peripheral arterial occlusive disease (PAOD).
Vascular medicine (London, England)·2002
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
The New England journal of medicine·2002
ACE inhibition and vascular remodeling of resistance vessels: vascular compliance and cardiovascular implications.
Heart disease (Hagerstown, Md.)·2001
The Cancer-Associated Lipid Paradox: Implications for Cardiovascular Risk and Lipid Management.
The American journal of cardiology·2026
Safe and Fast Radial Artery Hemostasis Using Synergistic Strategies: SAFE and FAST Trial.
The American journal of cardiology·2026
Coronary Aneurysmal and Ectatic Disease: Cath-Lab Diagnosis and Contemporary Interventional Management.
The American journal of cardiology·2026
Racial and Ethnic Differences in Transcatheter Coarctation Repair among Adolescents and Adults.
The American journal of cardiology·2026
Associations of Cholesin and GPR146 with atherosclerotic plaque stability: integrated bioinformatics and functional analyses.
Frontiers in cardiovascular medicine·2026
Caveolin-1 levels associated with coronary artery disease in Chinese participants: a retrospective cohort study.
Frontiers in cardiovascular medicine·2026
PCSK9 inhibitors for lipid-lowering treatment in patients with atherosclerotic cardiovascular disease: a health technology assessment.
Frontiers in cardiovascular medicine·2026